Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Will FDA's Fast-Track Program Boost Drug Manufacturing?
Research & Development Will FDA's Fast-Track Program Boost Drug Manufacturing?

Amid growing health crises and increasing global competition in pharmaceuticals, a novel FDA initiative aims to fast-track drug reviews by slashing approval times for essential medicines. Can this new approach significantly impact domestic drug manufacturing, or does it introduce unprecedented

Can AI-Enhanced MRI Revolutionize Preventive Healthcare?
Tech & Innovation Can AI-Enhanced MRI Revolutionize Preventive Healthcare?

The healthcare landscape is poised to undergo a seismic shift with the introduction of AI-enhanced whole-body MRI technology, promising to revolutionize preventive health screening. CoreViva, a pioneering diagnostic imaging clinic located in Newport Beach, California, is at the forefront of this

Roche Advances Parkinson's Drug Prasinezumab to Phase 3 Trials
Research & Development Roche Advances Parkinson's Drug Prasinezumab to Phase 3 Trials

With over ten million people worldwide battling Parkinson's disease, the quest for a treatment that not only controls symptoms but also halts the progression of this neurological disorder is of immense importance. Roche's recent advancement of prasinezumab, developed with Prothena, into Phase 3

Why Is Pediatric Imaging Market Set to Double by 2034?
Tech & Innovation Why Is Pediatric Imaging Market Set to Double by 2034?

The pediatric imaging market, currently valued at $8.7 billion, has attracted significant attention due to its anticipated growth trajectory towards $18.1 billion by 2034. This remarkable expansion is driven in part by a projected compound annual growth rate of 7.7% from 2025 to 2034, indicating a

Can ProBio's Hopewell Facility Revolutionize Gene Therapy?
Biotech & Bioprocessing Can ProBio's Hopewell Facility Revolutionize Gene Therapy?

In a decisive leap toward revolutionizing gene therapy, ProBio has unveiled its cutting-edge facility in Hopewell, New Jersey. This facility is poised to become a key player in the production of high-quality plasmid, lentiviral, and adeno-associated viral vectors tailored for genomic medicine. With

Gamma Knife Radiosurgery for Brain Metastases in Ovarian Cancer
Research & Development Gamma Knife Radiosurgery for Brain Metastases in Ovarian Cancer

In this engaging conversation with biopharma expert Ivan Kairatov, we delve into the complexities and innovations in treating brain metastases from ovarian cancer. Ivan shares insights from a recent study that evaluated the effectiveness of Gamma Knife Stereotactic Radiosurgery (GKSRS) in managing

AI and Film Animation Propel Coronavirus Drug Discovery
Tech & Innovation AI and Film Animation Propel Coronavirus Drug Discovery

The unforeseen impact of the COVID-19 pandemic initiated a global rush not only to discover vaccines but also to explore effective antiviral drugs capable of counteracting multiple coronaviruses. This effort has evolved beyond traditional scientific methods, incorporating surprising and innovative

Do New Genes Hold the Key to Human Cell Division?
Research & Development Do New Genes Hold the Key to Human Cell Division?

Ivan Kairatov, a notable expert in biopharma with a rich background in tech and innovation within the industry, lends his insights on a recent groundbreaking study in human cell cycle regulation. The study, led by the team at EPFL, unveils how newly evolved genes are integral to the complex process

Can Personalized Diets Revolutionize Food Sensitivity Research?
Research & Development Can Personalized Diets Revolutionize Food Sensitivity Research?

Personalized diets are emerging as a beacon of hope in the complex world of food sensitivity research, offering potential solutions to a pervasive and intricate problem. Food sensitivities, distinct from well-known allergies, are linked to immune responses involving IgA and IgG antibodies. These

Are Patient-Friendly Drug Formulations the Future of Cancer Care?
Management & Regulatory Are Patient-Friendly Drug Formulations the Future of Cancer Care?

The field of cancer treatment has witnessed significant innovations, especially in the formulation of drugs designed to ease patient administration. The European Medicines Agency's endorsement of zanubrutinib tablets, Brukinsa's newer form, highlights an essential shift toward treatments that

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later